✦ LIBER ✦

Outpatient 5-fluorouracil +α-interferon + interleukin-2 chemoimmunotherapy in metastatic renal cell cancer patients

✍ Scribed by Ozlem ER; Metin OZKAN; Mustafa ALTINBAS; Hasan Senol COSKUN; Bulent ESER; Fevzi ALTUNTAS; Mustafa CETIN; Ali UNAL

Book ID: 111318564
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 96 KB
Volume: 1
Category: Article
ISSN: 1743-7555
DOI: 10.1111/j.1743-7563.2005.00021.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Outpatient treatment with subcutaneous i

Outpatient treatment with subcutaneous interleukin-2, interferon alpha and fluorouracil in patients with metastatic renal cancer: an Australian experience

✍ G. Marx; J. Taylor; D. Goldstein 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

Interleukin-2, Interferon-α and 5-Fluoro

Interleukin-2, Interferon-α and 5-Fluorouracil Immunotherapy for Metastatic Renal Cell Carcinoma: The All Ireland Experience

✍ M.F O’Brien; D Rea; E Rogers; H Bredin; M Butler; R Grainger; T.E.D McDermott; G 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 247 KB

Phase II trial of interleukin 2, interfe

Phase II trial of interleukin 2, interferon α, and 5-fluorouracil in metastatic renal cell cancer: a cytokine working group study.

✍ JP Dutcher; T Logan; M Gordon; J Sosman; G Weiss; K Margolin; T Plasse; J Mier; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Phase II trial of 5-fluorouracil, interf

Phase II trial of 5-fluorouracil, interferon-α and continuous infusion interleukin-2 for patients with metastatic renal cell carcinoma

✍ Julie A. Ellerhorst; Avishay Sella; Robert J. Amato; Shi-Ming Tu; Randall E. Mil 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views

## RESULTS. Fifty-five patients were enrolled in the trial and 52 were evaluable for ogy, The University of Texas M. D. Anderson response. All patients experienced fever and flu-like symptoms. Grade 3 or 4 nonhe-Cancer Center, Houston, Texas. matologic toxic effects included hypertension (48%), d

Immunochemotherapy with interleukin-2, i

Immunochemotherapy with interleukin-2, interferon- α and 5-fluorouracil for progressive metastatic renal cell carcinoma: a multicenter phase II study

✍ Herpen, C.M.L.v. 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 70 KB

Histologic Subtype of Metastatic Renal C

Histologic Subtype of Metastatic Renal Cell Carcinoma Predicts Response to Combined Immunochemotherapy with Interleukin 2, Interferon α and 5-Fluorouracil

✍ Edwin Herrmann; Olaf Anselm Brinkmann; Marc-Eric Bode; Stefan Bierer; Thomas Köp 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 146 KB